Thursday, 5 November 2026European Markets

LISGRAFICA Stock Soars 33% In 21 Sessions: Is This Bullish Momentum Here To Stay?

Loading stream...

(VIANEWS) - LISGRAFICA (PSI: LIG.LS) shares have experienced an extraordinary surge over the last 21 days, increasing by 33.33% from EUR0.01 to EUR0.01 at 15:33 EST on Monday; however, its momentum took a drastic downward turn during Tuesday's trading session with PSI declining by 0.89% to EUR6,148.52 as of today's market close. LISGRAFICA stock closed yesterday at EUR0.01, representing a 26.32% discount from its 52-week high of EUR0.101. This decline may have been caused by factors such as market volatility, company news or general economic trends. Investors should carefully observe LISGRAFICA's performance and remain up-to-date on news and events that impact its performance, in order to make well-informed decisions regarding their investments in LISGRAFICA.

About LISGRAFICA

Lisgrafica - Impressao e Artes Graficas, S.A. is a printing company founded in 1973 in Agualva-Cacem, Portugal and specializing in producing various printed materials like magazines, newspapers, supplements, catalogs, brochures and telephone directories. Rasografica - Comercio e Servicos Graficos S.A is its parent company.

Yearly Analysis

Based on available information, LISGRAFICA's stock is currently trading at EUR0.01, higher than its 52-week high of EUR0.01 which indicates that performance has been excellent throughout this year and reaching its highest point during that time period. Without further examination of LISGRAFICA's financial health, industry trends, and other relevant factors it is difficult to provide an in-depth investment outlook for their stock. Investors are advised to conduct thorough research on LISGRAFICA's fundamentals such as its financial statements, management team, competitive landscape etc. before making their investment decision and seeking professional advice to make sure their chosen investment aligns with both individual financial goals and risk tolerance levels.

Technical Analysis

LISGRAFICA Stock Price Movements: LISGRAFICA has experienced recent fluctuations in price. Recently, its prices have been significantly above both its 50-day moving average (EUR0.01) and 200-day moving average (EUR0.01). Yet despite this fact, its last reported volume is 99.93% lower than its average volume of 29698, suggesting less trading activity overall. Looking at LISGRAFICA's volatility, it can be seen that it experienced a positive 4.17% change during the last week, negative 0.83% change over the last month and positive 17.30% over the last quarter. Furthermore, average volatility reached 12.50% during these three timeframes with highest amplitude at 12.50% during week one and 19.044% at month end and 17.30% during quarter end. Additionally, LISGRAFICA's stock was identified by the stochastic oscillator as being oversold (=20). Though past performance can provide clues as to future outcomes, investors should remain mindful that past results do not guarantee future ones. Therefore, extensive research must be completed prior to making investment decisions.

Quarter Analysis

Based on the provided data, it appears that this company's year-on-year quarterly revenue growth has decreased by 12% over time and now stands at $9.78M for twelve trailing months. This may cause investors to become concerned as it signals slowing revenue growth could indicate struggling business or challenges due to competitive pressure or other obstacles; investors should carefully consider this information and conduct additional research in order to assess financial health and future prospects of this firm.

Equity Analysis

Based on the available EPS information for LISGRAFICA, it has reported a trailing twelve month EPS of EUR-0.026; meaning they have reported negative earnings per share over the last year. Investors should keep in mind that a negative EPS may signal to them that a company may not yet be profitable; however, other factors must also be taken into consideration such as revenue growth, industry trends and overall financial health before making investment decisions. Investors may wish to examine LISGRAFICA's financial statements and reports in order to gain a deeper insight into its profitability and future growth potential. Furthermore, it may be useful comparing LISGRAFICA's EPS against that of its rivals to see where LISGRAFICA stands in its industry.

More news about LISGRAFICA (LIG.LS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com